1. Home
  2. UGI vs CYTK Comparison

UGI vs CYTK Comparison

Compare UGI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UGI Corporation

UGI

UGI Corporation

HOLD

Current Price

$37.05

Market Cap

8.1B

Sector

Utilities

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.06

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGI
CYTK
Founded
1940
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
UGI
CYTK
Price
$37.05
$63.06
Analyst Decision
Buy
Strong Buy
Analyst Count
1
16
Target Price
$44.00
$82.38
AVG Volume (30 Days)
1.9M
2.2M
Earning Date
02-04-2026
02-26-2026
Dividend Yield
4.03%
N/A
EPS Growth
147.20
N/A
EPS
3.09
N/A
Revenue
$7,287,000,000.00
$87,211,000.00
Revenue This Year
$21.37
$346.43
Revenue Next Year
$3.03
$57.69
P/E Ratio
$12.04
N/A
Revenue Growth
1.07
2609.26
52 Week Low
$28.25
$29.31
52 Week High
$39.59
$70.98

Technical Indicators

Market Signals
Indicator
UGI
CYTK
Relative Strength Index (RSI) 45.57 50.68
Support Level $36.69 $60.30
Resistance Level $37.82 $65.25
Average True Range (ATR) 0.65 2.84
MACD -0.19 0.11
Stochastic Oscillator 24.44 60.08

Price Performance

Historical Comparison
UGI
CYTK

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: